BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 17994454)

  • 1. Effect of intravenous iron sucrose on oxidative stress in peritoneal dialysis patients.
    Saglam F; Cavdar C; Uysal S; Cavdar Z; Camsari T
    Ren Fail; 2007; 29(7):849-54. PubMed ID: 17994454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
    Cavdar C; Temiz A; Yeniçerioğlu Y; Calişkan S; Celik A; Sifil A; Onvural B; Camsari T
    Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
    Swarnalatha G; Ram R; Neela P; Naidu MU; Dakshina Murty KV
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):852-8. PubMed ID: 20814119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
    Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
    Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease.
    Erichsen K; Ulvik RJ; Nysaeter G; Johansen J; Ostborg J; Berstad A; Berge RK; Hausken T
    Scand J Gastroenterol; 2005 Sep; 40(9):1058-65. PubMed ID: 16165718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress and ferritin levels in haemodialysis patients.
    Senol E; Ersoy A; Erdinc S; Sarandol E; Yurtkuran M
    Nephrol Dial Transplant; 2008 Feb; 23(2):665-72. PubMed ID: 18039638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of ascorbate-rich dialysate to attenuate oxidative stress in maintenance hemodialysis patients.
    Shi XF; Ding F; Zhu QY; Xue J; Lu FM; Gu Y; Lin ST
    Ren Fail; 2005; 27(2):213-9. PubMed ID: 15807188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficiency of fractionated parenteral iron treatment in CAPD patients.
    Akcicek F; Ozkahya M; Cirit M; Ok E; Unsal A; Toz H; Celik A; Atabay G; Basci A
    Adv Perit Dial; 1997; 13():109-12. PubMed ID: 9360661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of serum albumin level on iron-induced oxidative stress in chronic renal failure patients.
    Sezer MT; Akin H; Demir M; Erturk J; Aydin ZD; Savik E; Tunc N
    J Nephrol; 2007; 20(2):196-203. PubMed ID: 17514624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour necrosis factor alpha, lipid peroxidation and NO* are increased and associated with decreased free-radical scavenging enzymes in patients with Weill-Marchesani syndrome.
    Evereklioglu C; Turkoz Y; Calis M; Duygulu F; Karabulut AB
    Mediators Inflamm; 2004 Jun; 13(3):165-70. PubMed ID: 15223607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous iron sucrose changes the intraperitoneal homeostasis.
    Breborowicz A; Połubinska A; Kupczyk M; Wanic-Kossowka M; Oreopoulos DG
    Blood Purif; 2009; 28(1):53-8. PubMed ID: 19325240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant enzymes show adaptation to oxidative stress in athletes and increased stress in hemodialysis patients.
    Knap B; Prezelj M; Buturović-Ponikvar J; Ponikvar R; Bren AF
    Ther Apher Dial; 2009 Aug; 13(4):300-5. PubMed ID: 19695063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant therapy by oral vitamin E and vitamin E-coated dialyzer in CAPD and haemodialysis patients.
    Mydlík M; Derzsiová K; Rácz O; Sipulová A; Lovásová E
    Prague Med Rep; 2006; 107(3):354-64. PubMed ID: 17385408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of therapy on the antioxidant status in patients with melanoma.
    Gadjeva V; Dimov A; Georgieva N
    J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective effect of melatonin on nicotine-induced myocardial injury in newborn rats whose mothers received nicotine.
    Baykan A; Narin N; Narin F; Akgün H; Yavaşcan S; Saraymen R
    Anadolu Kardiyol Derg; 2008 Aug; 8(4):243-8. PubMed ID: 18676298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between cardiovascular complication and inflammation, oxidative stress of patient with maintenance hemodialysis].
    Zuo C; Qiu HY; Li Z; Xie XS; Fan JM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 39(1):119-21, 129. PubMed ID: 18390217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidant/antioxidant status of placenta, blood, and cord blood samples from pregnant women supplemented with iron.
    Devrim E; Tarhan I; Ergüder IB; Durak I
    J Soc Gynecol Investig; 2006 Oct; 13(7):502-5. PubMed ID: 16990032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
    Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
    Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione, glutathione-related enzymes, and total antioxidant capacity in patients on maintenance dialysis.
    Ahmadpoor P; Eftekhar E; Nourooz-Zadeh J; Servat H; Makhdoomi K; Ghafari A
    Iran J Kidney Dis; 2009 Jan; 3(1):22-7. PubMed ID: 19377255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.